Skip to main content
Xiamen Kingdomway Group Company logo

Xiamen Kingdomway Group Company — Investor Relations & Filings

Ticker · 002626 ISIN · CNE1000018X4 LEI · 655600MMA0SXX6IGL429 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,989 across all filing types
Latest filing 2026-06-03 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 002626

About Xiamen Kingdomway Group Company

https://www.kingdomway.com

Xiamen Kingdomway Group Company focuses on the research, development, and production of nutritional enhancers and health supplements. The company is a prominent global manufacturer of Coenzyme Q10 (CoQ10), Vitamin A, and Vitamin D3. Its product range extends to microalgae DHA, ARA, and other specialized nutritional ingredients. Kingdomway manages a comprehensive supply chain that encompasses the biotechnological synthesis of raw materials and the production of finished consumer health goods. Utilizing advanced fermentation and chemical synthesis technologies, the company supplies high-purity ingredients for applications in human health and animal nutrition. Through strategic expansion and technical innovation, it maintains a significant role in the global supply of essential vitamins and antioxidants, catering to diverse international requirements for quality-controlled nutritional components.

Recent filings

Filing Released Lang Actions
2025年年度权益分派实施公告
Notice of Dividend Amount Classification · 92% confidence The document is a corporate announcement outlining the 2025 annual equity distribution (“权益分派”) plan: it specifies the cash dividend per share, record date, ex-dividend date, total amount, calculation methodology, and payment details. This matches the definition of a Notice of Dividend Amount (Code: DIV). It is not a full financial report, but rather an announcement of dividend details.
2026-06-03 Chinese
关于权益分派实施后调整回购股份价格上限的公告
Transaction in Own Shares Classification · 95% confidence The document is an official announcement by the company regarding adjustments to the upper limit price for its share repurchase plan following a dividend distribution. It details the share buyback scheme, price changes, dates, and calculations, which falls squarely under reporting of transactions in own shares. This matches the “Transaction in Own Shares” category (POS).
2026-06-03 Chinese
关于可转换公司债券转股价格调整的公告
Capital/Financing Update Classification · 85% confidence The document is an official announcement by Xiamen Kingdawei Group concerning an adjustment to the conversion price of its outstanding convertible bonds (127111 “金威转债”). This is a standalone corporate disclosure about a financing instrument and a change in capital structure, not a financial report, dividend notice, management change, or proxy solicitation. It falls squarely under updates on company fundraising/financing activities or capital structure changes. Therefore, it should be classified as a Capital/Financing Update (CAP).
2026-06-03 Chinese
关于取得发明专利证书的公告
Regulatory Filings Classification · 75% confidence The document is an announcement (“公告”) by Xiamen Jindawei Group regarding the grant of an invention patent certificate. It is neither a financial report (e.g., annual, quarterly, earnings release) nor a securities transaction or shareholder vote. It is a general regulatory announcement about intellectual property, fitting the fallback category “Regulatory Filings (RNS).”
2026-05-28 Chinese
关于实施权益分派期间金威转债暂停转股的公告
Capital/Financing Update Classification · 85% confidence The document is a formal exchange announcement regarding the company’s convertible bond (“金威转债”)—specifically suspending conversion rights during an equity distribution period. It details bond code, suspension dates, issuance background, and adjustment formulas, which is not an AGM material, earnings release, or full financial report. This is neither a director trading notice nor a proxy statement, but rather an update on a financing instrument and its conversion terms. Therefore it best fits “Capital/Financing Update” (CAP).
2026-05-27 Chinese
关于首次回购公司股份的公告
Transaction in Own Shares Classification · 85% confidence The document is a formal announcement detailing the company’s first share repurchase, including the board resolution, repurchase quantities, prices, funding source, and regulatory compliance under share buyback rules. This matches the “Transaction in Own Shares” category.
2026-05-15 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.